The role of oocyte maturity in the treatment of infertility because of teratozoospermia and normozoospermia with gamete intrafallopian transfer

Simple item page
dc.contributor.authorVan der Merwe J.P.
dc.contributor.authorKruger T.F.
dc.contributor.authorSwart Y.
dc.contributor.authorLombard C.J.
dc.date.accessioned2011-05-15T16:16:28Z
dc.date.available2011-05-15T16:16:28Z
dc.date.issued1992
dc.description.abstractObjective: To determine the effect of oocyte maturity on pregnancy rate (PR) in patients undergoing gamete intrafallopian transfer (GIFT) procedures for infertility and in whom male partners had either normozoospermia or teratozoospermia. Design: A prospective study using a combination of clomiphene citrate and human menopausal gonadotropin for ovulation induction was carried out. Five hundred thirty-seven GIFT treatment cycles were analyzed, and 423 cycles yielded four or more oocytes. Patients were divided into two groups according to the sperm morphology: those with < 14% normal forms and those with >14% normal morphology (as judged by strict criteria). These two groups were divided into a further five subcategories depending on the number of metaphase II oocytes transferred. Results: In the group < 14% normal forms (category I; 4 metaphase I oocytes replaced), three pregnancies resulted from 33 cycles (9.09%), and in category V (4 metaphase II oocytes transferred) the PR was 15% (14/95) per cycle. In the group with >14% normal forms, in category I, the PR was 16% (3/19) per cycle, and in category V, the PR was 33% (20/61) per cycle. The effect of morphology (< 14% normal forms versus >14% normal forms) on pregnancy outcome is significant (P = 0.0161). The overall effect of increasing the number of metaphase II oocytes on the pregnancy outcome was not significant (P = 0.1098). However, in the group with >14% normal forms, there was a significant improvement in PR (P = 0.04) in category V. Conclusion: During this prospective study, it was shown that sperm morphology plays a significant role in the pregnancy outcome in a GIFT program.
dc.description.versionArticle
dc.identifier.citationFertility and Sterility
dc.identifier.citation58
dc.identifier.citation3
dc.identifier.issn00150282
dc.identifier.urihttp://hdl.handle.net/10019.1/13792
dc.subjectclomifene citrate
dc.subjecthuman menopausal gonadotropin
dc.subjectarticle
dc.subjectfemale
dc.subjectgamete intrafallopian transfer
dc.subjecthuman
dc.subjectinfertility
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmetaphase
dc.subjectoocyte
dc.subjectoocyte maturation
dc.subjectovulation induction
dc.subjectpregnancy rate
dc.subjectpriority journal
dc.subjectsperm
dc.subjectspermatozoon abnormality
dc.subjectFemale
dc.subjectGamete Intrafallopian Transfer
dc.subjectHuman
dc.subjectInfertility, Male
dc.subjectMale
dc.subjectMetaphase
dc.subjectOocytes
dc.subjectPregnancy
dc.subjectSpermatozoa
dc.titleThe role of oocyte maturity in the treatment of infertility because of teratozoospermia and normozoospermia with gamete intrafallopian transfer
dc.typeArticle
Files
Collections
Stellenbosch University - Scopus Tygerberg Hospital Publications